Silexion Therapeutics raises $1M through warrants exercise
Silexion Therapeutics has signed an agreement for the immediate exercise of around 2M outstanding warrants at a reduced price of $0.50 per share.
The deal is expected to raise around $1M in gross proceeds.
The company announced the agreement on Friday, with the exercise price set at $0.50 per share.